Research Article| Volume 18, ISSUE 8, P539-544, October 2008

Download started.


Moderate alcohol consumption and lipoprotein-associated phospholipase A2 activity

Published:December 03, 2007DOI:


      Background and aims

      To investigate the effect of moderate alcohol consumption on lipoprotein-associated phospholipase A2 activity, markers of inflammation and oxidative stress and whether these effects are modified by BMI.

      Methods and results

      Eleven lean (BMI: 18.5–25 kg/m2) and 9 overweight (BMI>27 kg/m2) men participated in a randomized controlled crossover trial. After consuming 3 cans of beer (40 g ethanol) or alcohol-free beer daily during 3 weeks, fasting blood samples were taken. HDL cholesterol increased by 18.2% (p<0.001) after beer compared to alcohol-free beer, while LDL cholesterol decreased by 7.8% (p=0.008). Lipoprotein-associated phospholipase A2 activity was not different (p=0.23) between beer (47.5±0.8) and alcohol-free beer (48.9±0.8). High-sensitive C-reactive protein was unaffected, but urinary isoprostanes tended to increase (p=0.09) after beer (114.0±6.9) compared to alcohol-free beer (96.9±6.5). An interaction between BMI and treatment (p<0.05) on liver enzymes was observed, indicating an increase of liver enzymes after moderate alcohol consumption in overweight men only.


      Despite profound effects on HDL and LDL cholesterol, moderate alcohol consumption did not affect lipoprotein-associated phospholipase A2 activity. Liver enzymes increased after alcohol consumption in overweight men only, suggesting a less favorable response to moderate alcohol consumption in overweight people.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Nutrition, Metabolism and Cardiovascular Diseases
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Grobbee D.E.
        • Rimm E.B.
        • Keil U.
        • Renaud S.
        Alcohol and the cardiovascular system.
        in: MacDonald I. Health issues related to alcohol consumption. 2nd ed. Blackwell Sciences Ltd, Bodmin1999: 125-179
        • Sierksma A.
        • van der Gaag M.S.
        • Kluft C.
        • Hendriks H.F.
        Moderate alcohol consumption reduces plasma C-reactive protein and fibrinogen levels; a randomized, diet-controlled intervention study.
        Eur J Clin Nutr. 2002; 56: 1130-1136
        • Hendriks H.F.
        • Veenstra J.
        • Velthuis-te Wierik E.J.
        • Schaafsma G.
        • Kluft C.
        Effect of moderate dose of alcohol with evening meal on fibrinolytic factors.
        BMJ. 1994; 308: 1003-1006
        • Davies M.J.
        • Baer D.J.
        • Judd J.T.
        • Brown E.D.
        • Campbell W.S.
        • Taylor P.R.
        Effects of moderate alcohol intake on fasting insulin and glucose concentrations and insulin sensitivity in postmenopausal women: a randomized controlled trial.
        JAMA. 2002; 287: 2559-2562
        • Sierksma A.
        • Patel H.
        • Ouchi N.
        • Kihara S.
        • Funahashi T.
        • Heine R.J.
        • et al.
        Effect of moderate alcohol consumption on adiponectin, tumor necrosis factor-alpha, and insulin sensitivity.
        Diabetes Care. 2004; 27: 184-189
        • van der Gaag M.S.
        • van Tol A.
        • Scheek L.M.
        • James R.W.
        • Urgert R.
        • Schaafsma G.
        • et al.
        Daily moderate alcohol consumption increases serum paraoxonase activity; a diet-controlled, randomised intervention study in middle-aged men.
        Atherosclerosis. 1999; 147: 405-410
        • Beulens J.W.
        • Sierksma A.
        • van Tol A.
        • Fournier N.
        • van Gent T.
        • Paul J.L.
        • et al.
        Moderate alcohol consumption increases cholesterol efflux mediated by ABCA1.
        J Lipid Res. 2004; 45: 1716-1723
        • Rimm E.B.
        • Williams P.
        • Fosher K.
        • Criqui M.
        • Stampfer M.J.
        Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors.
        BMJ. 1999; 319: 1523-1528
        • Zalewski A.
        • Macphee C.
        Role of lipoprotein-associated phospholipase A2 in atherosclerosis: biology, epidemiology, and possible therapeutic target.
        Arterioscler Thromb Vasc Biol. 2005; 25: 923-931
        • Rodrigo L.
        • Mackness B.
        • Durrington P.N.
        • Hernandez A.
        • Mackness M.I.
        Hydrolysis of platelet-activating factor by human serum paraoxonase.
        Biochem J. 2001; 354: 1-7
        • Koenig W.
        • Khuseyinova N.
        • Lowel H.
        • Trischler G.
        • Meisinger C.
        Lipoprotein-associated phospholipase A2 adds to risk prediction of incident coronary events by C-reactive protein in apparently healthy middle-aged men from the general population: results from the 14-year follow-up of a large cohort from southern Germany.
        Circulation. 2004; 110: 1903-1908
        • Oei H.H.
        • van der Meer I.
        • Hofman A.
        • Koudstaal P.J.
        • Stijnen T.
        • Breteler M.M.
        • et al.
        Lipoprotein-associated phospholipase A2 activity is associated with risk of coronary heart disease and ischemic stroke: the Rotterdam study.
        Circulation. 2005; 111: 570-575
        • Helander A.
        Biological markers in alcoholism.
        J Neural Transm Suppl. 2003; 66: 15-32
        • James O.F.W.
        • Day C.P.
        Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance.
        J Hepatol. 1999; 29: 495-501
        • Perry I.J.
        • Wannamethee S.G.
        • Shaper A.G.
        Prospective study of serum gamma-glutamyltransferase and risk of NIDDM.
        Diabetes Care. 1998; 21: 732-737
        • van Barneveld T.
        • Seidell J.C.
        • Traag N.
        • Hautvast J.G.
        Fat distribution and gamma-glutamyl transferase in relation to serum lipids and blood pressure in 38-year old Dutch males.
        Eur J Clin Nutr. 1989; 43: 809-818
        • Wannamethee G.
        • Ebrahim S.
        • Shaper A.G.
        Gamma-glutamyltransferase: determinants and association with mortality from ischemic heart disease and all causes.
        Am J Epidemiol. 1995; 142: 699-708
        • Bruckert E.
        • Giral P.
        • Ratziu V.
        • Poynard T.
        • Chapman M.J.
        • Opolon P.
        • et al.
        A constellation of cardiovascular risk factors is associated with hepatic enzyme elevation in hyperlipidemic patients.
        Metabolism. 2002; 51: 1071-1076
        • Poikolainen K.
        • Vartiainen E.
        Determinants of gamma-glutamyltransferase: positive interaction with alcohol and body mass index, negative association with coffee.
        Am J Epidemiol. 1997; 146: 1019-1024
      1. Voedingscentrum. Zo eet Nederland 1998; resultaten van de Voedselconsumptiepeiling 1998. Den Haag; 2003.

        • Friedewald W.T.
        • Levy R.I.
        • Fredrickson D.S.
        Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.
        Clin Chem. 1972; 18: 499-502
        • Sarkola T.
        • Dahl H.
        • Eriksson C.J.
        • Helander A.
        Urinary ethyl glucuronide and 5-hydroxytryptophol levels during repeated ethanol ingestion in healthy human subjects.
        Alcohol. 2003; 38: 347-351
        • Griffiths H.R.
        • Moller L.
        • Bartosz G.
        • Bast A.
        • Bertoni-Freddari C.
        • Collins A.
        • et al.
        Mol Aspects Med. 2002; 23: 101-208
        • Morrow J.D.
        • Zackert W.E.
        • Yang J.P.
        • Kurhts E.H.
        • Callewaert D.
        • Dworski R.
        • et al.
        Quantification of the major urinary metabolite of 15-F2t-isoprostane (8-iso-PGF2alpha) by a stable isotope dilution mass spectrometric assay.
        Anal Biochem. 1999; 269: 326-331
        • Baer D.J.
        • Judd J.T.
        • Clevidence B.A.
        • Muesing R.A.
        • Campbell W.S.
        • Brown E.D.
        • et al.
        Moderate alcohol consumption lowers risk factors for cardiovascular disease in postmenopausal women fed a controlled diet.
        Am J Clin Nutr. 2002; 75: 593-599
        • Clevidence B.A.
        • Reichman M.E.
        • Judd J.T.
        • Muesing R.A.
        • Schatzkin A.
        • Schaefer E.J.
        • et al.
        Effects of alcohol consumption on lipoproteins of premenopausal women. A controlled diet study.
        Arterioscler Thromb Vasc Biol. 1995; 15: 179-184
        • Naissides M.
        • Mamo J.C.
        • James A.P.
        • Pal S.
        The effect of chronic consumption of red wine on cardiovascular disease risk factors in postmenopausal women.
        Atherosclerosis. 2006; 185: 438-445
        • van der Gaag M.S.
        • Sierksma A.
        • Schaafsma G.
        • van Tol A.
        • Geelhoed-Mieras T.
        • Bakker M.
        • et al.
        Moderate alcohol consumption and changes in postprandial lipoproteins of premenopausal and postmenopausal women: a diet-controlled, randomized intervention study.
        J Womens Health Gend Based Med. 2000; 9: 607-616
        • Schaefer E.J.
        • McNamara J.R.
        • Asztalos B.F.
        • Tayler T.
        • Daly J.A.
        • Gleason J.L.
        • et al.
        Effects of atorvastatin versus other statins on fasting and postprandial C-reactive protein and lipoprotein-associated phospholipase A2 in patients with coronary heart disease versus control subjects.
        Am J Cardiol. 2005; 95: 1025-1032
        • Imhof A.
        • Woodward M.
        • Doering A.
        • Helbecque N.
        • Loewel H.
        • Amouyel P.
        • et al.
        Overall alcohol intake, beer, wine, and systemic markers of inflammation in western Europe: results from three MONICA samples (Augsburg, Glasgow, Lille).
        Eur Heart J. 2004; 25: 2092-2100
        • Hartman T.J.
        • Baer D.J.
        • Graham L.B.
        • Stone W.L.
        • Gunter E.W.
        • Parker C.E.
        • et al.
        Moderate alcohol consumption and levels of antioxidant vitamins and isoprostanes in postmenopausal women.
        Eur J Clin Nutr. 2005; 59: 161-168
        • Kichian K.
        • McLean R.
        • Gramlich L.M.
        • Bailey R.J.
        • Bain V.G.
        Nonalcoholic fatty liver disease in patients investigated for elevated liver enzymes.
        Can J Gastroenterol. 2003; 17: 38-42